ZEBREFINE: Optimisation of anesthesia in zebrafish: Economic, clinical and animal welfare implications (Q2906579): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: co-financing rate (P837): 85.0 percentage) |
(Changed an Item: Import item from Portugal) |
||||||||||
| Property / budget | Property / budget | ||||||||||
| 238,985.3 Euro
| ||||||||||
| Property / EU contribution | Property / EU contribution | ||||||||||
| 203,137.51 Euro
| ||||||||||
| Property / priority axis | |||||||||||
| Property / priority axis: Strengthening research, technological development and innovation (OT1) / rank | |||||||||||
Normal rank | |||||||||||
| Property / co-financing rate | |||||||||||
85.0 percent
| |||||||||||
| Property / co-financing rate: 85.0 percent / rank | |||||||||||
Normal rank | |||||||||||
Revision as of 01:48, 5 November 2022
Project Q2906579 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ZEBREFINE: Optimisation of anesthesia in zebrafish: Economic, clinical and animal welfare implications |
Project Q2906579 in Portugal |
Statements
203,137.51 Euro
0 references
238,985.3 Euro
0 references
85.0 percent
0 references
26 July 2018
0 references
25 December 2021
0 references
INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR - IBMC
0 references
Q2985732 (Deleted Item)
0 references
Identifiers
POCI-01-0145-FEDER-029542
0 references